1793P PPROSTRATEGY: A SOGUG randomized trial of androgen deprivation therapy (ADT) plus docetaxel (dct) +/- nivolumab (nivo) or ipilimumab-nivolumab (ipi-nivo) in high-volume metas... von Arranz Arija, J.A., Vazquez Estevez, S., Alonso Gordoa, T., Sepúlveda Sánchez, J.M., Perez Valderrama, B., Climent Duran, M.A., Gallardo Diaz, E., Lázaro Quintela, M., Lainez Milagro, N., Domenech Santasusana, M., Gonzalez del Alba Baamonde, M.A., Abad Villar, M.T., Crespo Herrero, G., Alvarez Fernandez, C., Mellado Gonzalez, B., Zambrana Tevar, F.J., Lopez Lopez, C., Perez Ramirez, S., Villa Guzmán, J.C., Piulats Rodriguez, J.M.

Volltext

42P Real-life data on treatment with poly (ADP-ribose) polymerase inhibitor (iPARP), in patients over 65 years of age with ovarian cancer: A current need von Martinez Cutillas, M., Garitaonaindia Diaz, Y., Nunez Garcia, B., Blanco Clemente, M., Traseira Puchol, C., Aguado, R., Visedo, G., Gónzalez Sánchez, A., Ruiz de Domingo, D.I., Sánchez Del Corral, M.M., Gonzalez Del Alba Baamonde, M.A., Sanchez Gonzalez, J.C., Cantos Sanchez de Ibarguen, B., Mendez Garcia, M., Provencio Pulla, M., Maximiano Alonso, C.

Volltext

78P Cardiotoxicity in cancer patients treated with immune-checkpoint inhibitors von Franco, F.F., Garitaonaindía, Y., Blanco Clemente, M., Torrente, M., Calvo de Juan, V., Collazo Lorduy, A., Gutierrez, L., Sánchez, J.C., Gonzalez del Alba Baamonde, M.A., Royuela, A., Visedo, G., González, S.C., Martinez Cutillas, M., Traseira Puchol, C., Aguado, R., Mitroi, C.D., Provencio, M.

Volltext

Differential gene expression profiles in poor vs good responders to maintenance vinflunine in patients (p) with advanced urothelial carcinoma (aUC): Preliminary results of biomarke... von Ramirez, J.L., Font Pous, A., Garcia-Donas, J., Perez Valderrama, B., Aguirre Egaña, I., Nonell, L., Ruiz de Porras Fontdevila, V., Mallo, M., Balañá, D., Virizuela, J.A., Anido, U., Llorente Ostiategui, M.M., Gonzalez del Alba Baamonde, M.A., Lainez, N., Mellado, B., Climent Duran, M.A., Bellmunt, J.

Volltext

Preliminary safety results of the randomized phase II ABIDO-SOGUG trial: Toxicity profile of concomitant abiraterone acetate + docetaxel treatment in comparison to docetaxel von Puente, J., Mendez Vidal, M.J., Saez, M.I., Font Pous, A., Duran, I., Castellano, D., Juan Fita, M.J., Santander, C., Arranz Arija, J.A., Sanchez-Hernandez, A., Mellado, B., Alonso, T., Gonzalez del Alba Baamonde, M.A., Maroto, P., Lazaro, M., Esteban, E., Cassinello, J.G., Climent Duran, M.A.

Volltext

PRORADIUM: Prospective multicentre study of prognostic factors in castration resistant prostate cancer (CRPC) patients treated with radium-223 von Morales Barrera, R., Sáez, M.I., Romero-Laorden, N., Lozano Mejorada, R., Lorente Estelles, D., de Velasco, G., Gonzalez Del Alba Baamonde, M.A., Gonzalez Billalabeitia, E., Medina, A., Borrega García, P., Rodriguez-Vida, A., Ferrandiz Brotons, U., Fernandez Calvo, O., García Domínguez, R., Puente, J., Piulats Rodriguez, J.M., Villatoro, R., Castro Marcos, E., Olmos Hidalgo, D.

Volltext

PROSENZA: Prospective multi-centre study of prognostic factors in castration resistant prostate cancer (CRPC) patients treated with enzalutamide (ENZ) von Medina, A., Montesa, A., Romero Laorden, N., Gonzalez-Billalabeitia, E., Rodriguez-Vida, A., Grau, G., Garcés, T., Morales Barrera, R., Vazquez Mazon, F.J., Villatoro, R., Gonzalez Del Alba Baamonde, M.A., López, F., Hernando Polo, S., Domenech, M., de Velasco, G., Borrega, P., Querol, R., Velez, E., Castro Marcos, E., Olmos Hidalgo, D.

Volltext

PROREPAIR-B: A prospective cohort study of DNA repair defects in metastatic castration resistant prostate cancer (mCRPC) von Marcos, E. Castro, Romero Laorden, N., Rodriguez, J.M. Piulats, del Pozo, A., Sáez, M.I., Colmenero, A. Medina, Puente, J., Silla-Castro, J.C., Mejorada, R. Lozano, Garcia-Carbonero, I., Rivera, L., Vidal, M.J. Mendez, Barrera, R. Morales, Parra, E.M. Fernandez, Flórez, Y. Cendón, Borrega, P., Del Alba Baamonde, M.A. Gonzalez, Pritchard, C., Lapunzina, P., Hidalgo, D. Olmos

Volltext

A phase II clinical trial of radium-223 activity in patients (pts) with metastatic castration-resistant prostate cancer (mcrpc) with asymptomatic progression while on abiraterone a... von Carles Galceran, J., Bonfill Abella, T., Borrega, P., Collado, R., Garde, J., Gonzalez del Alba Baamonde, M.A., Grande Pulido, E., Mellado, B., Mendez Vidal, M.J., Piulats Rodriguez, J.M., Morales Barrera, R., Gallardo Diaz, E., Paredes, P., Suarez Rodriguez, C., Reig, O., Vazquez Estevez, S.

Volltext

SPAZO2 (SOGUG): Validation of the international metastatic database consortium (IMDC) prognostic classification for targeted therapies as 2nd-line after 1st-line pazopanib (1stPz)... von Pérez-Valderrama, B., Arranz Arija, J., Chirivella González, I., Anido Herranz, U., Jurado García, J.M., Suarez Rodriguez, C., García Carbonero, I., de Velasco, G., García Domínguez, R., García Marrero, R.D., Gonzalez Del Alba Baamonde, M.A., Molins Palau, C., Lazaro, M.E., Munoz-Langa, J., Martinez Ortega, E., Hernández Jorge, A., Campayo Guillaumes, M., Sereno Moyano, M., Luque Caro, R., Rodríguez Sánchez, Á.

Volltext

2635 MAJA trial: maintenance vinflunine post cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC). Preliminary analysis of a randomized placebo controlle... von Jiménez, J. Garcia Donas, Valderrama, B. Pérez, Pous, A. Font, Echaburu, J.A. Virizuela, Durán, M.A. Climent, Polo, S. Hernando, González, B. Mellado, Milagro, N. Láinez, del Alba Baamonde, M.A. González, Arija, J.A. Arranz, Guzmán, J.C. Villa, Ostiategui, M.D.M. Llorente, Gauna, D. Castellano, Díaz, E. Gallardo, del Muro Solans, X. Garcia, Herranz, U. Anido, Santasusana, M. Domènech, Vázquez, J. Puente, Gracia, J.L. Pérez, Molins, J. Bellmunt

Volltext